Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-02

Clinical Trial Update: Preliminary Efficacy and Safety of Apremilast in the Treatment of Acne Conglobata [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating apremilast for acne conglobata reports preliminary efficacy and safety findings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Apremilast (apremilast)

Snippet

Sponsor: Dr. Frank Behrens | Conditions: Acne Conglobata | Phase 2 | Status: COMPLETED